Literature DB >> 21252542

Apolipoprotein E polymorphism and age at onset of Alzheimer's disease in a quadriethnic sample.

Oh Dae Kwon1, Aisha Khaleeq, Wenyaw Chan, Valory N Pavlik, Rachelle S Doody.   

Abstract

BACKGROUND: The relationship between the apolipoprotein E (ApoE) genotype and the risk for developing Alzheimer's disease (AD) or age at onset of AD is relatively well established in Caucasians, but less established in other ethnicities. We examined the association between the ApoE genotype and age at onset of AD in a quadriethnic group of community-dwelling AD patients.
METHODS: AD patients were evaluated at 2 university-based outpatient memory disorder clinics. The ethnic distribution was as follows: Caucasians (n = 1,083), Hispanics (n = 55), African Americans (n = 84) and Koreans (n = 87). All were diagnosed with probable AD according to NINCDS-ADRDA diagnostic criteria.
RESULTS: After adjusting for ethnicity, the ε4 allele was significantly associated with earlier age at onset (p < 0.0001) for the combined group. Within ethnic groups, the effect of Apo ε4 on age at onset was significant in Caucasians (p < 0.0001) and African Americans (p < 0.05), but nonsignificant in Koreans (p = 0.43) and in the smaller Hispanic (p = 0.07) group.
CONCLUSIONS: The association between Apo ε4 and younger age at onset was significant in Caucasians and African Americans, where the ε4 allele was also most frequent. This study suggests that the impact of ApoE polymorphism on age at onset of AD may be different among distinct ethnic groups.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21252542     DOI: 10.1159/000322368

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  13 in total

1.  APOE-epsilon4 and aging of medial temporal lobe gray matter in healthy adults older than 50 years.

Authors:  Joy L Taylor; Blake K Scanlon; Michelle Farrell; Beatriz Hernandez; Maheen M Adamson; J Wesson Ashford; Art Noda; Greer M Murphy; Michael W Weiner
Journal:  Neurobiol Aging       Date:  2014-05-15       Impact factor: 4.673

2.  Genetic association of apolipoprotein E polymorphisms with inflammatory bowel disease.

Authors:  Ebtissam Saleh Al-Meghaiseeb; Mulfi Mubarak Al-Otaibi; Abdulrahman Al-Robayan; Reem Al-Amro; Ahmd Saad Al-Malki; Misbahul Arfin; Abdulrahman K Al-Asmari
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

3.  APOE genotype, hippocampus, and cognitive markers of Alzheimer's disease in American Indians: Data from the Strong Heart Study.

Authors:  Astrid Suchy-Dicey; Barbara Howard; W T Longstreth; Eric M Reiman; Dedra Buchwald
Journal:  Alzheimers Dement       Date:  2022-02-10       Impact factor: 16.655

4.  Which neuropsychological tests predict progression to Alzheimer's disease in Hispanics?

Authors:  Gali H Weissberger; David P Salmon; Mark W Bondi; Tamar H Gollan
Journal:  Neuropsychology       Date:  2013-05       Impact factor: 3.295

5.  Younger age of dementia diagnosis in a Hispanic population in southern California.

Authors:  L Jaime Fitten; Freddy Ortiz; Lynn Fairbanks; George Bartzokis; Po Lu; Eric Klein; Giovanni Coppola; John Ringman
Journal:  Int J Geriatr Psychiatry       Date:  2014-01-29       Impact factor: 3.485

6.  Non-replication of an association of Apolipoprotein E2 with sinistrality.

Authors:  Brian J Piper; Alia L Yasen; Amy E Taylor; Jonatan R Ruiz; J William Gaynor; Catherine A Dayger; Marcela Gonzalez-Gross; Oh D Kwon; Lars-Göran Nilsson; Ian N M Day; Jacob Raber; Jeremy K Miller
Journal:  Laterality       Date:  2012-06-21

7.  Lack of Association between Apolipoprotein E Polymorphism with Age at Onset of Subcortical Vascular Dementia.

Authors:  Hye Guk Ryu; Sung-Won Youn; Oh Dae Kwon
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2012-01-19

8.  Screening and Evaluation of Deleterious SNPs in APOE Gene of Alzheimer's Disease.

Authors:  Tariq Ahmad Masoodi; Sulaiman A Al Shammari; May N Al-Muammar; Adel A Alhamdan
Journal:  Neurol Res Int       Date:  2012-03-13

9.  Novel 5' untranslated region directed blockers of iron-regulatory protein-1 dependent amyloid precursor protein translation: implications for down syndrome and Alzheimer's disease.

Authors:  Sanghamitra Bandyopadhyay; Catherine Cahill; Amelie Balleidier; Conan Huang; Debomoy K Lahiri; Xudong Huang; Jack T Rogers
Journal:  PLoS One       Date:  2013-07-31       Impact factor: 3.240

10.  Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study.

Authors:  Adam C Naj; Gyungah Jun; Christiane Reitz; Brian W Kunkle; William Perry; Yo Son Park; Gary W Beecham; Ruchita A Rajbhandary; Kara L Hamilton-Nelson; Li-San Wang; John S K Kauwe; Matthew J Huentelman; Amanda J Myers; Thomas D Bird; Bradley F Boeve; Clinton T Baldwin; Gail P Jarvik; Paul K Crane; Ekaterina Rogaeva; M Michael Barmada; F Yesim Demirci; Carlos Cruchaga; Patricia L Kramer; Nilufer Ertekin-Taner; John Hardy; Neill R Graff-Radford; Robert C Green; Eric B Larson; Peter H St George-Hyslop; Joseph D Buxbaum; Denis A Evans; Julie A Schneider; Kathryn L Lunetta; M Ilyas Kamboh; Andrew J Saykin; Eric M Reiman; Philip L De Jager; David A Bennett; John C Morris; Thomas J Montine; Alison M Goate; Deborah Blacker; Debby W Tsuang; Hakon Hakonarson; Walter A Kukull; Tatiana M Foroud; Eden R Martin; Jonathan L Haines; Richard P Mayeux; Lindsay A Farrer; Gerard D Schellenberg; Margaret A Pericak-Vance; Marilyn S Albert; Roger L Albin; Liana G Apostolova; Steven E Arnold; Robert Barber; Lisa L Barnes; Thomas G Beach; James T Becker; Duane Beekly; Eileen H Bigio; James D Bowen; Adam Boxer; James R Burke; Nigel J Cairns; Laura B Cantwell; Chuanhai Cao; Chris S Carlson; Regina M Carney; Minerva M Carrasquillo; Steven L Carroll; Helena C Chui; David G Clark; Jason Corneveaux; David H Cribbs; Elizabeth A Crocco; Charles DeCarli; Steven T DeKosky; Malcolm Dick; Dennis W Dickson; Ranjan Duara; Kelley M Faber; Kenneth B Fallon; Martin R Farlow; Steven Ferris; Matthew P Frosch; Douglas R Galasko; Mary Ganguli; Marla Gearing; Daniel H Geschwind; Bernardino Ghetti; John R Gilbert; Jonathan D Glass; John H Growdon; Ronald L Hamilton; Lindy E Harrell; Elizabeth Head; Lawrence S Honig; Christine M Hulette; Bradley T Hyman; Gregory A Jicha; Lee-Way Jin; Anna Karydas; Jeffrey A Kaye; Ronald Kim; Edward H Koo; Neil W Kowall; Joel H Kramer; Frank M LaFerla; James J Lah; James B Leverenz; Allan I Levey; Ge Li; Andrew P Lieberman; Chiao-Feng Lin; Oscar L Lopez; Constantine G Lyketsos; Wendy J Mack; Frank Martiniuk; Deborah C Mash; Eliezer Masliah; Wayne C McCormick; Susan M McCurry; Andrew N McDavid; Ann C McKee; Marsel Mesulam; Bruce L Miller; Carol A Miller; Joshua W Miller; Jill R Murrell; John M Olichney; Vernon S Pankratz; Joseph E Parisi; Henry L Paulson; Elaine Peskind; Ronald C Petersen; Aimee Pierce; Wayne W Poon; Huntington Potter; Joseph F Quinn; Ashok Raj; Murray Raskind; Barry Reisberg; John M Ringman; Erik D Roberson; Howard J Rosen; Roger N Rosenberg; Mary Sano; Lon S Schneider; William W Seeley; Amanda G Smith; Joshua A Sonnen; Salvatore Spina; Robert A Stern; Rudolph E Tanzi; Tricia A Thornton-Wells; John Q Trojanowski; Juan C Troncoso; Otto Valladares; Vivianna M Van Deerlin; Linda J Van Eldik; Badri N Vardarajan; Harry V Vinters; Jean Paul Vonsattel; Sandra Weintraub; Kathleen A Welsh-Bohmer; Jennifer Williamson; Sarah Wishnek; Randall L Woltjer; Clinton B Wright; Steven G Younkin; Chang-En Yu; Lei Yu
Journal:  JAMA Neurol       Date:  2014-11       Impact factor: 18.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.